Written Questions are submitted by MPs or Lords to receive information from a Department.
|5 Sep 2017, 2:32 p.m.||Breast Cancer: Drugs||Nick Thomas-Symonds|
To ask the Secretary of State for Health, what recent discussions his Department has had with clinicians and patient groups on improving the implementations of bisphosphonates for the prevention of secondary breast cancer.
Answer (Steve Brine)
The National Institute for Health and Care Excellence (NICE) is currently updating its guidelines on the diagnosis and management of early and locally advanced breast cancer. The use of adjuvant bisphosphonates has been identified as one of the key areas that will be covered in the update which is scheduled for publication in July 2018. In the meantime, NICE will shortly be publishing an evidence summary on the use of adjuvant bisphosphonates in early breast cancer. NHS England expects clinical commissioning groups to take account of NICE guidelines and local population needs when making commissioning decisions.